There was a significant difference between low and high E2F1 expression in DLBCL cases regarding the risk groups of AAIPI < 60, as 71% of cases with high risk group had high E2F1 expression (p = 0.049). This evidence concerns the gene E2F1 and diffuse large B-cell lymphoma.